|
RNF217 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.39220000475271E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.434300E-04 |
| Normal-vs-Stage2 |
1.790240E-02 |
| Normal-vs-Stage3 |
5.983500E-03 |
| Normal-vs-Stage4 |
1.519350E-01 |
| Stage1-vs-Stage2 |
3.030000E-01 |
| Stage1-vs-Stage3 |
1.268370E-01 |
| Stage1-vs-Stage4 |
3.722800E-01 |
| Stage2-vs-Stage3 |
5.782400E-01 |
| Stage2-vs-Stage4 |
6.077800E-01 |
| Stage3-vs-Stage4 |
8.147800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.91609999977693E-07 |
| Normal-vs-AfricanAmerican |
1.562760E-03 |
| Normal-vs-Asian |
8.312600E-01 |
| Caucasian-vs-AfricanAmerican |
6.135600E-01 |
| Caucasian-vs-Asian |
1.534330E-02 |
| AfricanAmerican-vs-Asian |
3.300300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78494999999446E-05 |
| Normal-vs-Female |
3.12910000022093E-07 |
| Male-vs-Female |
9.822500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.901600E-02 |
| Normal-vs-Extreme_Weight |
1.699680E-02 |
| Normal-vs-Obese |
3.98380000000698E-05 |
| Normal-vs-Extreme_Obese |
3.265800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.109600E-01 |
| Normal_Weight-vs-Obese |
2.553400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.923600E-01 |
| Extreme_Weight-vs-Obese |
1.895720E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.633200E-01 |
| Obese-vs-Extreme_Obese |
2.847000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.372200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.60680000205593E-08 |
| Normal-vs-Age(61-80Yrs) |
5.991000E-04 |
| Normal-vs-Age(81-100Yrs) |
8.826000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.707000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.215450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.471700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.199100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.832000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.088100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.08749999964076E-07 |
| Normal-VS-Type2 PRCC |
1.408020E-02 |
| Normal-VS-KIRP CIMP |
6.321200E-03 |
| Normal-VS-Unclassified PRCC |
8.407500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.523600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.172400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.226200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.822080E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.010430E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.344470E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.058500E-02 |
| Normal-vs-N1 |
2.177400E-03 |
| Normal-vs-N2 |
1.923550E-01 |
| N0-vs-N1 |
1.034100E-02 |
| N0-vs-N2 |
9.353600E-01 |
| N1-vs-N2 |
2.748400E-01 |
|
|
